Insurers Enact Policies to Ease Access to Prescription Drugs

According to a list compiled by America’s Health Insurance Plans (AHIP), payers have made a variety of changes to their prescription drug benefits as part of their response to the COVID-19 pandemic.

Payers that have waived early refill limits include: Anthem Inc., AvMed Inc., 36 regional affiliates of the Blue Cross and Blue Shield Association, Bright Health Inc., CareFirst Inc., Cigna Corp. (through home delivery), Fallon Community Health Plan Inc. (at in-network pharmacies), Geisinger Health Plan Inc., Harvard Pilgrim Health Care Inc., Humana Inc., Inter Valley Health Plan Inc. (for Part D members), Piedmont Community Health Plan and Valley Health Plan.

Payers that offer a home delivery or mail order option for prescriptions include: Arkansas Blue Cross and Blue Shield, AvMed, Blue Cross Blue Shield of Arizona, Cigna, EmblemHealth Inc. and Piedmont.

© 2024 MMIT
Peter Johnson

Peter Johnson

Peter has worked as a journalist since 2011 and has covered health care since 2020. At AIS Health, Peter covers trends in finance, business and policy that affect the health insurance and pharma sectors. For Health Plan Weekly, he covers all aspects of the U.S. health insurance sector, including employer-sponsored insurance, Medicaid managed care, Medicare Advantage and the Affordable Care Act individual marketplaces. In Radar on Drug Benefits, Peter covers the operations of (and conflicts between) pharmacy benefit managers and pharmaceutical manufacturers, with a particular focus on pricing dynamics and market access. Before joining AIS Health, Peter covered transportation, public safety and local government for various outlets in Seattle, his hometown and current place of residence. He graduated with a B.A. from Colby College.

Related Posts

businessman-viewing-news-update-journalism-headline-on-a-laptop
June 13

News Briefs: State Officials Urge SCOTUS Review of PBM Regulation Case

READ MORE
scientist-in-lab
June 13

Midsize Plans Struggle to Pay for Cell, Gene Therapies, Execs Say

READ MORE
injector-pen
June 13

Medicaid Programs Are Slow to Cover GLP-1s, but That Could Soon Change

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today